A prospective randomized trial of the antiemetic efficacy and cost-effectiveness of intravenous and orally disintegrating tablet of ondansetron in children with cancer.
Pediatric hematology and oncology, vol.22, pp.103-14, 2005 (Journal Indexed in SCI)
Article / Article
Title of Journal :
Pediatric hematology and oncology